From February 10, 2014 to March 31, 2014, the company has repurchased 162,147 shares, representing 2.24% for KRW 934.3 million. With this, the company has completed the repurchase of 162,147 shares, representing 2.24% for KRW 934.3 million under the buyback announced on February 10, 2014.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,000 KRW | +1.52% | +5.26% | +16.05% |
2023 | NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2019 | NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.05% | 171M | |
+16.33% | 19.96B | |
0.00% | 19.45B | |
+19.21% | 12.92B | |
-20.77% | 8.49B | |
+21.45% | 7.85B | |
+9.98% | 5.95B | |
-12.08% | 3.9B | |
-1.37% | 3.82B | |
-20.29% | 3.68B |
- Stock Market
- Equities
- A092730 Stock
- News NeoPharm CO., LTD.
- Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014.